Table 1. Patient characteristics.
| Patient | Gender | Chemo | Relapse | pT | pN | pM | Cancersubtype | Smoking status | UnamplifiedDNA (Tumor) | WGA DNA(Normal/Tumor) | RNA (Tumor) |
| 118 | Female | – | Yes | 2 | 0 | 0 | AC | Current | ✓ | ✓ | ✓ |
| 127 | Female | – | No | 2 | 0 | 0 | AC | Current | ✓ | ✓ | |
| 140 | Male | – | No | 2 | 0 | 1 | AC | Former | ✓ | ✓ | ✓ |
| 146 | Male | Cisplatin/Vinorelbine | Yes | 4 | 1 | 0 | AC | Former | ✓ | ✓ | |
| 210 | Female | Cisplatin/Vinorelbine | Yes | 1 | 2 | 0 | AC | Former | ✓ | ✓ | ✓ |
| 225 | Female | Cisplatin/Vinorelbine | No | 2 | 2 | 0 | AC | Current | ✓ | ✓ | ✓ |
| 247 | Female | Cisplatin/Vinorelbine | Yes | N/A | N/A | 0 | AC | Current | ✓ | ✓ | |
| 255 | Male | – | Yes | 2 | 2 | 0 | AC | Former | ✓ | ✓ | ✓ |
| 278 | Male | Cisplatin/Vinorelbine | No | 2 | 2 | 0 | AC | Current | ✓ | ✓ | ✓ |
| 295 | Female | – | Yes | 2 | 0 | 0 | AC | Former | ✓ | ✓ | ✓ |
| 322 | Male | Cisplatin/Vinorelbine | Yes | 2 | 2 | 0 | AC | Former | ✓ | ✓ | |
| 344 | Male | Cisplatin/Vinorelbine | No | 3 | 1 | 0 | AC | Former | ✓ | ✓ | ✓ |
| 396 | Male | – | Yes | 2 | 0 | 0 | AC | Current | ✓ | ✓ | ✓ |
| 412 | Male | – | No | 2 | 1 | 0 | SCC | Current | ✓ | ✓ | ✓ |
| 421 | Female | Cisplatin/Vinorelbine | Yes | 1 | 2 | 0 | AC | Current | ✓ | ✓ | ✓ |
| 541 | Female | – | No | 1 | 1 | 0 | AC | Current | ✓ | ✓ |
AC = Adenocarcinoma.
SCC = Squamous cell carcinoma.
pT = Postsurgical histopathological classification of primary tumour.
pN = Postsurgical histopathological classification of regional node.
pM = Postsurgical histopathological classification of distant metastasis.